Doxorubicin-induced apoptosis: Implications in cardiotoxicity

Molecular and Cellular Biochemistry

Volumn 234-235, Issue , 2002, Pages 119-124

  Kalyanaraman, B ^a   Joseph, Joy ^a   Kalivendi, Shashi ^a   Wang, Suwei ^a   Konorev, Eugene ^a   Kotamraju, Srigiridhar ^a  

^a FREE RADICAL RESEARCH CENTER   (United States)

Author keywords

Apoptosis; Caspase activation; Doxorubicin; Endothelial nitric oxide synthase; Reactive oxygen species

Indexed keywords

DOXORUBICIN; HYDROGEN PEROXIDE; IRON; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; CHELATING AGENT; RAZOXANE;

ANIMAL; APOPTOSIS; CARDIOMYOPATHY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL DEATH; CONCENTRATION RESPONSE; DRUG EXPOSURE; DRUG INHIBITION; ENDOTHELIUM CELL; FEMALE; GENETIC TRANSCRIPTION; HEART MUSCLE CELL; IRON CHELATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CARDIOMYOPATHIES; DOXORUBICIN; HUMANS; HYDROGEN PEROXIDE; IRON; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; ANIMAL; HUMAN; MYOCARDIAL DISEASES; NITRIC-OXIDE SYNTHASE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 4243907381     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015976430790     Document Type: Article

References (60)

1. Clinical spectrum of anthracycline cardiotoxicity
2. Adriamycin (NSC 123127) cardiomyopathy - An overview with determination of risk factors
3. Doxorubicin-induced cardiomyopathy
4. Subcellular effects of adriamycin in the heart: A concise review
5. Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane
6. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen
7. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor 1
8. Apoptosis in myocytes in end-stage heart failure
9. Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase: Effect of antiapoptotic anti-oxidants and calcium
10. Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells
11. Dual-mode EPR study of Mn(III) salen and the Mn(III) salen-catalyzed epoxidation of cis-beta-methylstyrene
12. Parallel polarization EPR characterization of the Mn(III) center of oxidized manganese superoxide dismutase
13. Role of iron in anthracycline cardiotoxicity: New tunes for an old song?
14. Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs
15. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin
16. The role of iron in doxorubicin-induced cardiomyopathy
17. Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes
18. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: The role of reactive oxygen and nitrogen intermediates
19. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase
20. Direct effects of adriamycin on the rat heart sarcolemma
21. Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin
22. Relative importance of intracellular glutathione peroxidase and catalase in vivo for prevention of peroxidation to the heart
23. Hydroperoxide metabolism in mammalian organs
24. Selenium and cardiovascular disease
25. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin
26. Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents
27. Release of iron from ferritin by cardiotoxic anthracycline antibiotics
28. The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium
29. Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex
30. Hydroxyl radical production and DNA damage induced by anthracycline-iron complex
31. Role of iron in anthracycline cardiotoxicity: New tunes for an old song?
32. Comparison of the effectiveness of (±)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles
33. Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer
34. Toxicity profile of dexrazoxane (Zinecard, ICRF-187, ADR-529, NSC-169780), a modulator of doxorubicin cardiotoxicity
35. Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity
36. Phase I trial of 96-h continuous infusion of dexrazoxane in patients with advanced malignancies
37. Regulating the fate of mRNA: The control of cellular iron metabolism
38. Oxidative stress induces activation of a cytosolic protein responsible for control of iron uptake
39. Rapid response to oxidative stress mediated by iron regulatory protein
40. Differences in the regulation of iron regulatory protein-1 (IRP-1) by extra- and intracellular oxidative stress
41. Inactivation of both RNA binding and aconitase activities of iron regulatory protein-1 by quinone-induced oxidative stress
42. Iron-sulfur clusters as biosensors of oxidants and iron
43. Regulating the fate of mRNA: The control of cellular iron metabolism
44. Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity: A protective stratagem against oxidative injury
45. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts
46. Apoptosis and heart failure: A critical review of the literature
47. Apoptosis - Basic mechanisms and implications for cardiovascular disease
48. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy
49. G2 block induced by DNA crosslinking agents and its possible consequences
50. Signalling apoptosis: A radical approach
51. The central executioners of apoptosis: Caspases or mitochondria?
52. Mitochondria and apoptosis
53. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
54. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis
55. Bcl-2 family members and the mitochondria in apoptosis
56. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
57. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis
58. The role of hydroxyl radical as a messenger in Cr(VI)-induced p53 activation
59. Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis
60. Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells